Vivoryon Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Vivoryon Therapeutics has a total shareholder equity of €26.3M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €30.8M and €4.5M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
Interest coverage ratio | n/a |
Cash | €28.58m |
Equity | €26.28m |
Total liabilities | €4.55m |
Total assets | €30.83m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VVYA's short term assets (€29.8M) exceed its short term liabilities (€3.2M).
Long Term Liabilities: VVYA's short term assets (€29.8M) exceed its long term liabilities (€1.4M).
Debt to Equity History and Analysis
Debt Level: VVYA is debt free.
Reducing Debt: VVYA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VVYA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VVYA has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 20.5% each year.